Quick Answer
Co-Diagnostics, Inc. reported Gross Profit of $400.1 thousand for fiscal year 2025.
Co-Diagnostics, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $400.1K | -86.3% |
| 2024 | $2.92M | +11.0% |
| 2023 | $2.63M | -90.9% |
| 2022 | $28.74M | -66.7% |
| 2021 | $86.31M | +48.9% |
| 2020 | $57.96M | +56424.0% |
| 2019 | $102.5K | +236.0% |
| 2018 | $30.5K | +314.7% |
| 2017 | $7.4K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $119.1K | -65.4% | -9.0% |
| June 30, 2025 | $130.8K | -94.6% | +356.0% |
| March 31, 2025 | $28.7K | -87.7% | -91.7% |
| September 30, 2024 | $343.7K | -84.4% | -85.9% |
| June 30, 2024 | $2.44M | +1035.6% | +947.7% |
| March 31, 2024 | $233.3K | +134.0% | -89.4% |
| September 30, 2023 | $2.20M | -49.1% | +942.5% |
| June 30, 2023 | -$261.3K | -106.4% | -362.0% |
- Co-Diagnostics, Inc. showed a decrease of -86.3% in Gross Profit compared to the prior fiscal year.
- Over the 2017–2025 period, Co-Diagnostics, Inc.’s gross profit has grown by 5336.3% (from $7.4 thousand to $400.1 thousand).
- The most recent figure is from Co-Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: